Skin papilloma – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:32:16 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Skin papilloma – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Effectiveness of Interferon Alfa, Interleukin-1, and Interleukin-2 in Treating Non-Genital Warts in Patients https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-interferon-alfa-interleukin-1-and-interleukin-2-in-treating-non-genital-warts-in-patients/ Wed, 29 Apr 2026 14:28:54 +0000 https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-interferon-alfa-interleukin-1-and-interleukin-2-in-treating-non-genital-warts-in-patients/ This clinical trial is focused on studying the treatment of warts, which are small, non-cancerous growths on the skin caused by a virus. The study will evaluate the effectiveness of two treatments, 2LVERU JUNIOR and 2LVERU, in comparison to a placebo. These treatments contain a combination of substances, including interferon alfa, interleukin-1, interleukin-2, ribonucleic acid, and specific nucleic acids known as SNA-HLA II and SNA-VERU. These substances are designed to help the body fight off the virus that causes warts.

The purpose of the study is to compare how well these treatments work in making warts disappear by the end of the treatment period, which lasts for six months. Participants in the study will be randomly assigned to receive either the 2LVERU treatments or a placebo. The study is conducted in a double-blind manner, meaning neither the participants nor the researchers know who is receiving the actual treatment or the placebo, to ensure unbiased results.

Throughout the study, participants will have regular check-ups to monitor the disappearance of warts and any potential side effects. The study will also assess the level of pain experienced and the use of pain relief medication. The main goal is to see if the warts disappear completely or partially, and to check if they come back after the treatment ends. Safety will be closely monitored by tracking any adverse events that may occur during the study.

]]>